CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report)’s stock price traded up 0.7% on Friday . The company traded as high as C$4.43 and last traded at C$4.43. 210 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 3,329 shares. The stock had previously closed at C$4.40.
CSPC Pharmaceutical Group Trading Up 0.7%
The company’s fifty day moving average is C$3.96 and its 200-day moving average is C$4.35.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Further Reading
- Five stocks we like better than CSPC Pharmaceutical Group
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
